Literature DB >> 12468010

Modified herpes simplex virus delivery of enhanced GFP into the central nervous system.

Vladislav M Sandler1, Samuel Wang, Kamilla Angelo, Helen G Lo, Xandra O Breakefield, David E Clapham.   

Abstract

Controlled expression of proteins is a key experimental approach to a deeper understanding of the molecular basis of neuronal function. Here we evaluate the HSV-1 (herpes simplex virus) amplicon vector for gene delivery into the brains of living rats. We demonstrate that HSV-1 amplicon vectors expressing enhanced green fluorescent protein (EGFP) can reliably infect neurons after it is injected into cortex, striatum and thalamus in rats, producing sufficient numbers of infected neurons for electrophysiological experiments in acute brain slices. Expression of EGFP delivered by the HSV-1 amplicon was detected for up to 5 weeks post-infection. We detected no changes in the morphology or the electrophysiological properties of thalamic, striatal or cortical neurons within a period of at least 2 weeks after HSV-1 amplicon injection. We conclude that the HSV-1 amplicon is a valuable tool for gene delivery in the rat central nervous system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12468010     DOI: 10.1016/s0165-0270(02)00262-5

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  3 in total

Review 1.  Herpes simplex virus-based vectors.

Authors:  Robin Lachmann
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

Review 2.  Genetic dissection of neural circuits.

Authors:  Liqun Luo; Edward M Callaway; Karel Svoboda
Journal:  Neuron       Date:  2008-03-13       Impact factor: 17.173

3.  A robust ex vivo experimental platform for molecular-genetic dissection of adult human neocortical cell types and circuits.

Authors:  Jonathan T Ting; Brian Kalmbach; Peter Chong; Rebecca de Frates; C Dirk Keene; Ryder P Gwinn; Charles Cobbs; Andrew L Ko; Jeffrey G Ojemann; Richard G Ellenbogen; Christof Koch; Ed Lein
Journal:  Sci Rep       Date:  2018-05-30       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.